Leucid Bio

London, United Kingdom

Leucid is progressing novel cart therapies that produce a better and more durable response.

$8.9M raised

Feb 2025

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Leucid Bio raised?

Leucid Bio has raised $8.9M in total funding. The most recent round was Series A. The last funding was announced in February 2025.

Who are Leucid Bio's investors?

Leucid Bio's investors include British Business Bank, Sofinnova Partners, Epidarex Capital, Vulpes Investment Management Pte Ltd, 2invest.

Where is Leucid Bio headquartered?

Leucid Bio is headquartered in London, United Kingdom.

What does Leucid Bio do?

Leucid is progressing novel cart therapies that produce a better and more durable response.

What stage is Leucid Bio at?

Leucid Bio is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 1, 2025.

MLA

"Leucid Bio — Funding & Investors." VCBacked, February 1, 2025, https://www.vcbacked.co/company/leucid-bio. Accessed July 9, 2026.

APA

VCBacked. (2025). Leucid Bio — Funding & Investors. Retrieved July 9, 2026, from https://www.vcbacked.co/company/leucid-bio

Wikipedia (cite web)

{{cite web |title=Leucid Bio — Funding & Investors |url=https://www.vcbacked.co/company/leucid-bio |website=VCBacked |access-date=July 9, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 1, 2025.